Quick answer. Fatty liver disease is a build-up of fat in the liver; its common metabolic form is now called MASLD (metabolic dysfunction-associated steatotic liver disease, formerly NAFLD). It is very common in Singapore – affecting up to around 1 in 3 adults (local research has cited about 40%) – and usually causes no symptoms, so it is often found by chance on an ultrasound or blood test. It is closely linked to obesity, type 2 diabetes and high cholesterol, and in some people can progress to inflammation, fibrosis, cirrhosis and even liver cancer. The mainstay of treatment is lifestyle change – gradual weight loss of about 7-10% of body weight, a healthy diet, exercise, limiting alcohol and sugary drinks, and controlling diabetes, cholesterol and blood pressure – and it is often reversible when caught early, so at-risk people should ask their doctor about screening.
Fatty liver disease is one of the most common health conditions in Singapore, yet most people who have it do not know it because it rarely causes symptoms. It simply means too much fat has built up in the liver. For many people this is harmless at first, but in some it can slowly cause inflammation and scarring over years. The good news is that, especially when caught early, fatty liver is often reversible with changes you can start making today. This guide explains what it is, who is at risk, how it is assessed, and what genuinely helps.
At a glance
| Stage / aspect | What it means | Notes |
|---|---|---|
| Simple fatty liver (steatosis / MASLD) | Excess fat in the liver without significant inflammation | Very common; usually no symptoms; often reversible with lifestyle change |
| Steatohepatitis (NASH / MASH) | Fat plus inflammation and liver-cell injury | Higher risk of progression; can still improve with weight loss and risk control |
| Fibrosis | Scar tissue forming as the liver tries to heal | Degree of fibrosis is the key driver of long-term risk; assessed with FibroScan |
| Cirrhosis | Advanced, extensive scarring impairing liver function | Can cause complications and needs specialist follow-up and cancer surveillance |
| Liver cancer (HCC) | Cancer arising in damaged liver tissue | Risk rises with cirrhosis; early detection through monitoring matters |
| Assessment tools | Blood tests, ultrasound, FibroScan, sometimes biopsy | Used together to confirm fat and, importantly, gauge scarring |
What is fatty liver disease (and what does MASLD mean)?
Fatty liver disease describes an abnormal build-up of fat in the liver. The most common form is metabolic in origin and is now called MASLD – metabolic dysfunction-associated steatotic liver disease. This is the same condition that doctors previously called NAFLD (non-alcoholic fatty liver disease); the name was updated internationally to better reflect that it is driven by metabolic problems such as excess weight, diabetes and high cholesterol.
A separate cause is heavy alcohol use, which leads to alcohol-related (alcohol-associated) liver disease. Some people have both metabolic risk factors and significant alcohol intake. Whatever the cause, the key point is the same: fat in the liver can be an early warning sign worth taking seriously.
How common is it in Singapore?
Fatty liver disease is very common here. Local studies and specialists have estimated that it affects a large share of the adult population – research involving Duke-NUS Medical School and Singapore General Hospital has cited a figure of up to around 40% of Singaporean adults, well above the global average of roughly a quarter to a third. It is often described as affecting around one in three adults.
Because Singapore has high rates of obesity, type 2 diabetes, high cholesterol and metabolic syndrome – and increasingly in younger people – fatty liver is expected to remain a major health issue. Crucially, it usually has no symptoms, so it is frequently picked up by chance on an abdominal ultrasound or when liver enzymes (ALT, AST) come back mildly raised on a routine blood test.
What causes it and who is at risk?
Metabolic fatty liver (MASLD) is part of the same cluster of problems as metabolic syndrome. The main risk factors include:
- Overweight or obesity, particularly central (abdominal) obesity – in Asian adults this is often defined as a waist over about 90cm for men and 80cm for women.
- Type 2 diabetes or insulin resistance.
- High cholesterol or high triglycerides.
- High blood pressure and overall metabolic syndrome.
- Related conditions such as obstructive sleep apnoea, polycystic ovary syndrome (PCOS) and an underactive thyroid.
Importantly, you can have a normal weight and still have fatty liver (“lean MASLD”). Separately, heavy alcohol use independently causes fat build-up and liver damage. If you have one or more of the metabolic risk factors above, you are in an at-risk group worth screening.
Why it matters: how fatty liver can progress
For many people, simple fatty liver stays stable and causes no harm. But in a proportion of people it can progress through a spectrum over years:
- Simple fatty liver (steatosis): fat in the liver without significant inflammation.
- Steatohepatitis (NASH / MASH): fat plus inflammation and liver-cell injury.
- Fibrosis: scar tissue starts to form as the liver tries to heal.
- Cirrhosis: extensive, advanced scarring that impairs liver function.
- Liver cancer (hepatocellular carcinoma): a risk that rises with cirrhosis, and can occasionally occur even before it.
Advanced disease can also bring symptoms such as fatigue, fluid build-up, easy bruising or bleeding, dark urine, jaundice and confusion. This progression is why fatty liver – though usually silent – is worth identifying and managing early, while it is still reversible.
How is fatty liver assessed?
Assessment usually combines several tools, and a doctor decides which are needed:
- Blood tests: liver function tests (including ALT and AST), plus checks for diabetes, cholesterol and other causes of liver disease. Scoring systems based on blood results can help estimate the risk of significant scarring.
- Ultrasound: a common, non-invasive scan that can detect fat in the liver – often how fatty liver is first found.
- FibroScan (transient elastography): a quick, painless scan that measures liver stiffness to gauge fibrosis (scarring) and can also estimate the amount of fat. It is widely used to decide who needs closer follow-up.
- Liver biopsy: occasionally used to confirm inflammation and stage the disease when the picture is unclear.
The goal is not just to confirm fat is present, but to work out whether any scarring has developed – that is what most affects long-term risk.
Treatment: lifestyle first
There is no quick-fix pill that replaces the basics – the mainstay of treatment is lifestyle change, which can reduce liver fat and, in many people, reverse inflammation and even some early scarring.
- Gradual weight loss: losing around 7-10% of body weight can significantly improve the liver (even 5% helps reduce liver fat). Steady, sustained loss is the aim – not crash dieting.
- Healthy diet: reduce refined sugar, sugary drinks, saturated and processed foods; emphasise vegetables, wholegrains, legumes, fish and healthy fats.
- Regular exercise: aim for at least 150 minutes a week of moderate activity such as brisk walking, cycling or swimming, ideally with some resistance training.
- Limit alcohol and avoid sugary beverages.
- Control your metabolic risks: keep diabetes, cholesterol and blood pressure well managed.
There is growing interest in medications for fatty liver, including newer drugs and treatments aimed at diabetes and weight, and a doctor may consider these in selected cases. But lifestyle change remains central, and any medication decision should be made with your doctor.
Related guides
- Best Gastroenterology Clinics in Singapore — our editorial shortlist
- gastroenterology clinics directory
- Acid reflux & GERD
- H. pylori, gastritis & ulcers
- Irritable bowel syndrome (IBS)
Sources
- SingHealth – Fatty Liver: Causes & Treatments
- Sengkang General Hospital (SingHealth) – Is My Liver Fat?
- SingHealth HealthXchange – Fatty Liver Disease on the Rise in Singaporeans
- Singapore Medical Journal – Managing non-alcoholic fatty liver disease
- Mayo Clinic – Fatty liver disease (MASLD): Symptoms and causes
See also
Related conditions & guides
Related conditions and guides you may find useful:
- Weight-Loss (Bariatric) Surgery in Singapore
- Childhood Obesity in Singapore
- Gallstones in Singapore
- Gastroscopy & Stomach (Gastric) Cancer Screening in Singapore
- Hepatitis B in Singapore
- Hepatitis C in Singapore
Part of our Digestive, liver & gut guides · Browse all health topics